CLB at a glance
Core Laboratories Inc. /DE/ (CLB, SEC CIK 1958086) filed its latest 10-K annual report on March 23, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on October 28, 2026 and Form 4 insider filings as recently as October 5, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Core Laboratories Inc. /DE/ (CLB) reported revenue of $526.5 million (up 0.5% from FY2024) and net income of $29.7 million. Diluted EPS was $0.63.
- As of September 30, 2026, 26 institutional investment managers tracked by SignalX reported holding Core Laboratories Inc. /DE/ (CLB) shares worth $166.7 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $526.5M
- +0.5% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 26 funds
- $166.7M · −1 vs prior quarter
- Latest 8-K
- Oct 28, 2026
- Item 2.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Revenue $132.1M, down 2% YoY from $134.5M
- Net income $5.5M, 4% margin vs 11% YoY; operating margin 9% vs 16%
- Best segment: Production Enhancement revenue $47.8M, up 3%, margin 9%; Reservoir Description revenue $84.3M, down 4%, margin 9% vs 19%
- Cash $21.4M vs $22.7M at December 31, 2025; operating cash flow $16.7M for nine months vs $29.1M
- Capital deployment: $14.4M capital expenditures, $7.7M share repurchases, $1.4M dividends; geopolitical conflicts and sanctions driving near-term volatility
Risk Factors
- No material changes disclosed from the December 31, 2025 Form 10-K risk factors
- Business performance risk: known or unknown risks could materially affect operations, financial position, or results
- Information risk: currently immaterial or unknown risks may impair business operations
AI summary of the CLB 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Third-quarter 2026 earnings release, providing the latest operating and financial update for Core Laboratories
- Full results and management commentary contained in the October 28, 2026 press-release exhibit
Item 7.01: Regulation FD Disclosure
- Quarterly cash dividend maintained at $0.01 per share
- Shareholder record date: November 9, 2026
Item EX-99.1: Item EX-99.1
- Q3 revenue $132.1M, up 6% sequentially but down 2% year-over-year, signaling recovery without full demand normalization
- Ex-items EPS $0.16, up 46% sequentially but down 27% year-over-year, with operating margin near 10%
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Director Kwaku Temeng resigning effective October 1, 2026
- Resignation reflects disagreement over strategic direction and governance practices
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 financial results announced on July 29, 2026
- Earnings details and operating performance contained in the accompanying press release exhibit
Item 7.01: Regulation FD Disclosure
- Quarterly cash dividend of $0.01 per share announced
- August 10, 2026 record date; August 31, 2026 payment date
Item EX-99.1: Item EX-99.1
- Q2 revenue $124.6M, down 4% YoY, while operating income $9.2M and EPS $0.13 reflected sequential recovery
- Production Enhancement drove momentum, with revenue up 15% sequentially to $45.9M and operating income up 550% sequentially to $5.2M
AI summaries of CLB 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CLB
Don't miss the next CLB filing
- Alerts as it files. A push when CLB files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CLB, by share count.
- Ask anything. An AI agent that reads every CLB filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Teo Sow Hang | M | Oct 1, 2026 | 250 | - |
| Tattoli Mark Damian | F | Oct 1, 2026 | 276 | $9.76 |
| Tattoli Mark Damian | M | Oct 1, 2026 | 700 | - |
| Teo Sow Hang | M | Oct 1, 2026 | 250 | - |
| Teo Sow Hang | F | Oct 1, 2026 | 99 | $9.76 |
| Tattoli Mark Damian | M | Oct 1, 2026 | 700 | - |
| Teo Sow Hang | M | Aug 1, 2026 | 200 | - |
| Teo Sow Hang | F | Aug 1, 2026 | 90 | $10.64 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $523.8M | $526.5M |
| Operating Income | - | $58.6M | $56.5M |
| Net Income | $36.7M | $31.4M | $29.7M |
| Op. Margin | - | 11.2% | 10.7% |
| Net Margin | - | 6.0% | 5.6% |
| Balance Sheet | |||
| Total Assets | - | $590.4M | $584.0M |
| Equity | $224.8M | $252.0M | $266.0M |
| ROE | 16.3% | 12.5% | 11.2% |
| Per Share | |||
| EPS | $0.77 | $0.66 | $0.63 |
| Cash Flow | |||
| Operating CF | - | $56.4M | $37.0M |
| CapEx | $10.6M | $13.0M | $11.2M |
Source: XBRL data in Core Laboratories Inc. /DE/ (CLB)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate CLB share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 26 | $166.7M |
| Q2 2026 | 27 | $213.0M |
| Q1 2026 | 28 | $291.7M |
| Q4 2025 | 26 | $278.8M |
| Q3 2025 | 29 | $217.4M |
| Q2 2025 | 27 | $219.1M |
| Q1 2025 | 25 | $176.2M |
| Q4 2024 | 21 | $193.4M |
- D.E. Shaw & Co+1.16M (+466%)
- Ameriprise Financial+669.9K (+677%)
- Citadel Advisors LLC+606.5K (+163%)
- Morgan Stanley+182.5K (+28%)
- AQR Capital Management+71.0K (+110%)
- BlackRock−2.95M (-40%)
- State Street Corp−619.1K (-28%)
- Vanguard Portfolio Management LLC−519.8K (-41%)
- Principal Financial Group−189.2K (-70%)
- Invesco Ltd−121.1K (-60%)
- Millennium Management+895.9K
- Two Sigma Investments+24.3K
- Prudential Financial−49.0K
- Renaissance Technologies LLC−14.5K
- FMR LLC (Fidelity)−4.5K
Source: 13F-HR filings on SEC EDGAR (aggregated from 209 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CLB filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 10-Q | Oct 30, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Oct 28, 2026 | - | Analysis | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 8-K | Aug 25, 2026 | - | Analysis | - |
| 4 | Aug 4, 2026 | - | - | - |
| 4 | Aug 4, 2026 | - | - | - |
| 4 | Aug 4, 2026 | - | - | - |
| 10-Q | Jul 30, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 29, 2026 | - | Analysis | - |
| 8-K | May 13, 2026 | - | Analysis | |
| 4 | May 4, 2026 | - | - | - |
| 10-Q | May 1, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 29, 2026 | - | Analysis | - |
| 4 | Apr 8, 2026 | - | - | - |
| 4 | Apr 7, 2026 | - | - | - |
| 4 | Apr 7, 2026 | - | - | - |
| 4 | Apr 7, 2026 | - | - | - |
| 4 | Apr 7, 2026 | - | - | - |
| 4 | Apr 7, 2026 | - | - | - |
| 8-K | Mar 23, 2026 | - | - | - |
| 10-K | Mar 23, 2026 | Dec 31, 2025 | - | |
| 8-K | Mar 17, 2026 | - | Analysis | - |
| 8-K | Mar 5, 2026 | - | Analysis | - |
| 4 | Feb 17, 2026 | - | - |
Related Energy companies
- XPRO · EXPRO GROUP HOLDINGS N.V.Oil & Gas Field Services, NEC
- HAL · HalliburtonOil & Gas Field Services, NEC
- HLX · HELIX ENERGY SOLUTIONS GROUP INCOil & Gas Field Services, NEC
- LBRT · Liberty Energy Inc.Oil & Gas Field Services, NEC
- TUSK · MAMMOTH ENERGY SERVICES, INC.Oil & Gas Field Services, NEC
- NESR · National Energy Services Reunited Corp.Oil & Gas Field Services, NEC
- NGS · NATURAL GAS SERVICES GROUP INCOil & Gas Field Services, NEC
- OII · OCEANEERING INTERNATIONAL INCOil & Gas Field Services, NEC
CLB SEC filings: frequently asked questions
Which institutions hold CLB stock?
As of September 30, 2026, the largest Core Laboratories Inc. /DE/ (CLB) holders among the 13F filers tracked by SignalX were BlackRock ($43.8 million), Dimensional Fund Advisors ($15.7 million), Vanguard Capital Management LLC ($15.3 million), State Street Corp ($15.1 million), D.E. Shaw & Co ($13.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CLB's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Core Laboratories Inc. /DE/ (CLB) reported revenue of $526.5 million (up 0.5% from FY2024) and net income of $29.7 million. Diluted EPS was $0.63. The figures come from the XBRL data in the 10-K.
What did CLB report in its latest 8-K?
Core Laboratories Inc. /DE/ (CLB) filed an 8-K on October 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Third-quarter 2026 earnings release, providing the latest operating and financial update for Core Laboratories.
What are the latest CLB SEC filings?
Core Laboratories Inc. /DE/ (CLB) filed its latest 10-K annual report on March 23, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on October 28, 2026 and a Form 4 insider filing on October 5, 2026.
What is CLB's SEC CIK number?
Core Laboratories Inc. /DE/ (CLB)'s SEC Central Index Key (CIK) is 1958086. EDGAR lists every CLB filing under that number.
Ask anything about CLB
The research agent reads CLB's filings, financials, insider trades and 13F holders, then answers with sources.